Document is current

Article History

Received: 27 June 2024

Accepted: 2 December 2024

First Online: 3 December 2024

Competing interests

: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The authors have read and understood Peritoneal Dialysis International’s policy on conflicts of interest disclosures. T. S. has received speaker honorarium from Baxter Healthcare and received research grant from Terumo Corporation. J. Z., C. T., B.B. and R, L. P. are employees of Arbor Research Collaborative for Health, which administers the DOPPS programs. M. C. has received travel support from Amgen and is supported by a Queensland Advancing Clinical Research Fellowship. J. P. has received speaking honoraria from AstraZeneca, Baxter Healthcare, DaVita Healthcare Partners, Fresenius Medical Care, Dialysis Clinics Incorporated and Satellite Healthcare. He has served as a consultant for Baxter Healthcare, DaVita Healthcare Partners, Fresenius Medical Care and LiberDi. K. T., H. K. and J. M. declare that they have no relevant financial interest.

: All methods were carried out in accordance with relevant guidelines and regulations. Study approval was obtained from a central institutional review board. Additional study approval and patient consent were obtained as required by national and local ethics committee regulations. Written informed consent was obtained from all patients eligible for study participation in accordance with the Declaration of Helsinki.